The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback